SABCS 2022 Conference Coverage
S

SABCS 2022 Adjuvant Paclitaxel & Trastuzumab for Node- HER2+ BC: Final 10-Year Results and HER2DX Analysis

By SABCS 2022 Conference Coverage FEATURING Sara Tolaney
December 19, 2022
1 Comment
Login to view comments. Click here to Login

Featured Video

17:04
Novartis Oncology

Discussion on Overall Survival Data Across 3 Phase III Trials in HR+…

Feat. G. Hortobagyi

Featured Video

18:15
Novartis Oncology

CDK4/6 Inhibitor in Postmenopausal Patients With HR+/HER2- mBC: Anal…

Feat. G. Hortobagyi

Related Content

AUTOPLAY
27:39
Breast Health Global Initiative

Metastatic Breast Disease: Treatment and Palliative Care

Feat. A. Eniu
17:54
Heather McArthur

Modern Immune Therapy in ER, HR+/HER2-, HER2+ Breast Cancer

24:03
Holy Cross 9th Annual Winter Oncology Symposium

Early Stage Breast Cancer - Comparison of Trials of Genomic Assays -…

Feat. R. L. Mahtani
24:33
Holy Cross 9th Annual Winter Oncology Symposium

Therapeutic Strategies in HER2+ Breast Cancer - Pertuzumab, Neratini…

Feat. B. Moy
12:05
Holy Cross 9th Annual Winter Oncology Symposium

Future Directions in the Targeting of HER2+ Breast Cancer: duration …

Feat. B. Moy
10:12
Holy Cross 9th Annual Winter Oncology Symposium

Emerging Targets in HER-2 Negative, TNBC and HER-3 Positive Breast C…

Feat. M. Abu-Khalaf
32:33
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Adjuvant Chemotherapy for HR+/HER2- Breast Cancer - How MINDACT, TAI…

Feat. L. Carey
07:58
Sandra Swain

ASCO 2019 End-of-study Survival Analysis from the Cleopatra Study Sh…

10:53
Baltic and Eurasia Masterclass in Clinical Oncology

Neoadjuvant Systemic Therapy for HER2 + Early Breast Cancer - Review…

Feat. A. Česas
19:04
Baltic and Eurasia Masterclass in Clinical Oncology

Adjuvant Systemic Therapy for HER2 + Early Breast Cancer - Neratinib…

Feat. A. Česas
10:00
12th ESO-EONS Masterclass in Oncology Nursing

Breast Cancer Global Epidemiology (Nurses)

Feat. O. Pagani
19:29
2019 Scripps MD Anderson's Oncology Update

ASCO Metastatic HER2+ Breast Review: How Long to Treat Is up To Deba…

Feat. J. Mortimer
15:37
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

47 y/o Female with HER2+ Breast Cancer: Management of Chemotherapy-I…

Feat. M. Aapro, R. Clark-Snow, P. Fernandez-Ortega, E. Roeland
12:02
ANCO’s ASCO Highlights 2019

ANCO's ASCO Update on Breast Cancer - Margetuximab + Chemo Impr…

Feat. H. Chew
10:06
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

NCCN Guidelines Update for TNBC and HER2 Breast Cancer: Immunotherap…

Feat. J. Abraham, W. Gradishar
18:20
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Review of HER2 Testing Guidelines in Breast Cancer With Cases - IHC …

Feat. D. Hicks
15:23
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Q&A on Clinical Data Behind Changing the Guidelines, Her2+ Testi…

Feat. D. Hicks
29:47
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Current State of Breast Cancer Vaccines: Testing Vaccines in Adjuvan…

Feat. G. Peoples
09:46
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

Current Concept of Breast Cancer Vaccines: Study on HER2 Directed Va…

Feat. G. Peoples
26:50
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

CAR-T Cell Therapy for Breast Cancer: Types of T-Cell Therapy, Ident…

Feat. S. Modi